专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US09133224B2 Macrocyclic kinase inhibitors 有权
标题翻译：大环激酶抑制剂
公开(公告)号：US09133224B2
公开(公告)日：2015-09-15
申请号：US13990045
申请日：2011-11-29
申请人： Andrew P. Crew , Hanqing Dong , Caterina Ferraro , Dan Sherman , Kam W. Siu
发明人： Andrew P. Crew , Hanqing Dong , Caterina Ferraro , Dan Sherman , Kam W. Siu
IPC分类号： A61K31/675 , C07F9/6584
CPC分类号： C07F9/6584 , A61K31/675
摘要： Compounds of Formula (I): wherein variables are defined herein, and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers for which FAK inhibition is beneficial.
摘要翻译：式（I）化合物：其中变量在本文中定义，以及其药学上可接受的盐，合成，中间体，制剂及其治疗方法，包括FAK抑制有益的癌症。

2. 发明申请

US20120196847A1 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors 有权
公开(公告)号：US20120196847A1
公开(公告)日：2012-08-02
申请号：US13446629
申请日：2012-04-13
申请人： Lee D. Arnold , Heather Coate , Andrew Philip Crew , Hanqing Dong , Kenneth Foreman , Ayako Honda , Radoslaw Laufer , An-Hu Li , Kristen Michelle Mulvihill , Mark Joseph Mulvihill , Anthony Nigro , Bijoy Panicker , Arno G. Steinig , Qingua Weng , Douglas S. Werner , Michael J. Wyle , Tao Zhang , Cara Cesario , Yingchuan Sun
发明人： Lee D. Arnold , Heather Coate , Andrew Philip Crew , Hanqing Dong , Kenneth Foreman , Ayako Honda , Radoslaw Laufer , An-Hu Li , Kristen Michelle Mulvihill , Mark Joseph Mulvihill , Anthony Nigro , Bijoy Panicker , Arno G. Steinig , Qingua Weng , Douglas S. Werner , Michael J. Wyle , Tao Zhang , Cara Cesario , Yingchuan Sun
IPC分类号： A61K31/4985 , A61K31/53 , A61P35/00 , A61K31/5377 , A61K31/551 , C07D487/04 , A61K31/519
CPC分类号： C07F5/025 , C07D471/04 , C07D487/04
摘要： Compounds of the formula and pharmaceutically acceptable salts thereof, wherein X1, X2, X3, X4, X5, X6, X7, R1, and Q1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.

3. 发明授权

US07388012B2 (Hydrazido)(amino)thiophene compounds 失效
标题翻译：（肼基）（氨基）噻吩化合物
公开(公告)号：US07388012B2
公开(公告)日：2008-06-17
申请号：US11227698
申请日：2005-09-15
申请人： Andrew Crew , An-Hu Li , Hanqing Dong , Tao Zhang
发明人： Andrew Crew , An-Hu Li , Hanqing Dong , Tao Zhang
IPC分类号： A61K31/4709 , A61K31/381 , A61K31/497 , C07D215/14 , C07D409/12 , C07D333/36 , C07D333/38
CPC分类号： C07D409/12 , C07D409/14
摘要： Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, wherein A and J are defined herein, are useful in the treatment of tumors and cancers such as mastocytosis/mast cell leukemia, gastrointestinal stromal tumors (GIST), germ cell tumors, small cell lung carcinoma (SCLC), sinonasal natural killer/T-cell lymphoma, testicular cancer (seminoma), thyroid carcinoma, malignant melanoma, ovarian carcinoma, adenoid cystic carcinoma, acute myelogenous leukemia (AML), breast carcinoma, pediatric T-cell acute lymphoblastic leukemia, neuroblastoma, mast cell leukemia, angiosarcoma, anaplastic large cell lymphoma, endometrial carcinoma, and prostate carcinoma.
摘要翻译：式（I）表示的化合物或其药学上可接受的盐或N-氧化物，其中A和J在本文中定义，可用于治疗肿瘤和癌症如肥大细胞增多症/肥大细胞白血病，胃肠道间质瘤（GIST），生殖细胞肿瘤，小细胞肺癌（SCLC），鼻窦自然杀伤/ T细胞淋巴瘤，睾丸癌（精原细胞瘤），甲状腺癌，恶性黑素瘤，卵巢癌，腺样囊性癌，急性骨髓性白血病（AML），乳腺癌，儿科T细胞急性淋巴细胞白血病，神经母细胞瘤，肥大细胞白血病，血管肉瘤，间变性大细胞淋巴瘤，子宫内膜癌和前列腺癌。

4. 发明申请

US20070208053A1 Fused heterobicyclic kinase inhibitors 审中-公开
标题翻译：融合的杂双环激酶抑制剂
公开(公告)号：US20070208053A1
公开(公告)日：2007-09-06
申请号：US11654814
申请日：2007-01-18
申请人： Lee Arnold , Xin Chen , Hanqing Dong , Andrew Garton , Mark Mulvihill , Colin Sambrook Smith , Gerard Thomas , Thomas Krulle , Jing Wang
发明人： Lee Arnold , Xin Chen , Hanqing Dong , Andrew Garton , Mark Mulvihill , Colin Sambrook Smith , Gerard Thomas , Thomas Krulle , Jing Wang
IPC分类号： C07D471/02 , A61K31/4745
CPC分类号： C07D471/04
摘要： Compounds of the formula and pharmaceutically acceptable salts thereof, wherein X1, X2, X3, X4, X5, X5, X7, R1, and Q1 are defined herein, inhibit kinase enzymes and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer. The compounds are also useful in the treatment of inflammation, allergy, asthma, disease and conditions of the immune system, disease and conditions of the nervous system, cardiovascular diseases, disease and conditions of the eye, dermatological diseases, osteoporosis, diabetes, multiple sclerosis, and infections.
摘要翻译：下式的化合物及其药学上可接受的盐，其中X 1，X 2，X 3，X 4， X 5，X 5，X 7，R 1和Q 1 在本文中定义，抑制激酶，并且可用于治疗和/或预防过度增殖性疾病如癌症。该化合物还可用于治疗炎症，过敏，哮喘，免疫系统的疾病和状况，神经系统的疾病和状况，心血管疾病，眼睛疾病和病症，皮肤病，骨质疏松症，糖尿病，多发性硬化和感染。

5. 发明申请

US20060211678A1 Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds 失效
标题翻译：芳基 - 氨基取代的吡咯并嘧啶多激酶抑制化合物
公开(公告)号：US20060211678A1
公开(公告)日：2006-09-21
申请号：US11194158
申请日：2005-08-01
申请人： Saleh Ahmed , Oscar Barba , Jason Bloxham , Graham Dawson , Wiliam Gattrell , John Kitchin , Neil Anthony Pegg , Imaad Saba , Shazia Sadiq , Colin Peter Sambrook Smith , Don Smyth , Amo Steing , Robin Wilkes , Bijoy Panicker , Paula Tavares , Matthew Cox , An-Hu Li , Hanqing Dong , Lifu Ma , Kenneth Foreman , Qinghua Weng , Kathryn Stolz
发明人： Saleh Ahmed , Oscar Barba , Jason Bloxham , Graham Dawson , Wiliam Gattrell , John Kitchin , Neil Anthony Pegg , Imaad Saba , Shazia Sadiq , Colin Peter Sambrook Smith , Don Smyth , Amo Steing , Robin Wilkes , Bijoy Panicker , Paula Tavares , Matthew Cox , An-Hu Li , Hanqing Dong , Lifu Ma , Kenneth Foreman , Qinghua Weng , Kathryn Stolz
IPC分类号： A61K31/5377 , A61K31/519 , A61K31/496 , A61K31/4745 , C07D487/02 , C07D471/02
CPC分类号： C07D471/02 , C07D487/02 , C07D487/04
摘要： Compounds represented by Formula (I): or stereoisomers or pharmaceutically acceptable salts thereof, are inhibitors of least two of the Abl, Aurora-A, Blk, c-Raf, cSRC, Src, PRK2, FGFR3, Flt3, Lck, Mek1, PDK-1, GSK3β, EGFR, p70S6K, BMX, SGK, CaMKII, Tie-2, IGF-1R, Ron, Ret, and KDR kinases in animals, including humans, for the treatment and/or prevention of various diseases and conditions such as cancer.
摘要翻译：由式（I）表示的化合物或其立体异构体或其药学上可接受的盐是Abl，Aurora-A，Blk，c-Raf，cSRC，Src，PRK2，FGFR3，Flt3，Lck，Mek1，PDK中的至少两种的抑制剂 -1，GSK3beta，EGFR，p70S6K，BMX，SGK，CaMKII，Tie-2，IGF-1R，Ron，Ret和KDR激酶，用于治疗和/或预防各种疾病和病症，癌症。

6. 发明申请

US20060063773A1 (Hydrazido)(amino)thiophene compounds 失效
标题翻译：（肼基）（氨基）噻吩化合物
公开(公告)号：US20060063773A1
公开(公告)日：2006-03-23
申请号：US11227698
申请日：2005-09-15
申请人： Andrew Crew , An-Hu Li , Hanqing Dong , Tao Zhang
发明人： Andrew Crew , An-Hu Li , Hanqing Dong , Tao Zhang
IPC分类号： A61K31/496 , A61K31/4709 , C07D409/02
CPC分类号： C07D409/12 , C07D409/14
摘要： Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, wherein A and J are defined herein, are useful in the treatment of tumors and cancers such as mastocytosis/mast cell leukemia, gastrointestinal stromal tumors (GIST), germ cell tumors, small cell lung carcinoma (SCLC), sinonasal natural killer/T-cell lymphoma, testicular cancer (seminoma), thyroid carcinoma, malignant melanoma, ovarian carcinoma, adenoid cystic carcinoma, acute myelogenous leukemia (AML), breast carcinoma, pediatric T-cell acute lymphoblastic leukemia, neuroblastoma, mast cell leukemia, angiosarcoma, anaplastic large cell lymphoma, endometrial carcinoma, and prostate carcinoma.
摘要翻译：由式（I）表示的化合物：

7. 发明授权

US08022206B2 Furo[3,2-C]pyridines 有权
标题翻译：呋喃并[3,2-C]吡啶
公开(公告)号：US08022206B2
公开(公告)日：2011-09-20
申请号：US12366743
申请日：2009-02-06
申请人： An-Hu Li , Arno G. Steinig , Andrew Kleinberg , Qinghua Weng , Mark J. Mulvihill , Jing Wang , Xin Chen , Ti Wang , Hanqing Dong , Meizhong Jin
发明人： An-Hu Li , Arno G. Steinig , Andrew Kleinberg , Qinghua Weng , Mark J. Mulvihill , Jing Wang , Xin Chen , Ti Wang , Hanqing Dong , Meizhong Jin
IPC分类号： C07D413/00 , C07D403/00 , C07D471/02
CPC分类号： C07D491/048
摘要： Furo[3,2-c]Pyridine and Thieno[3,2-c]pyridine compounds of Formula I, and pharmaceutically acceptable salts thereof, preparation, intermediates, pharmaceutical compositions, and use, such as in disease treatment, including cancers, including conditions in which EMT is involved, including conditions mediated by protein kinase activity such as RON and/or MET.
摘要翻译：呋喃并[3,2-c]吡啶和噻吩并[3,2-c]吡啶化合物及其药学上可接受的盐，制剂，中间体，药物组合物和用途，例如疾病治疗包括癌症，包括涉及EMT的病症，包括蛋白激酶活性介导的病症，如RON和/或MET。

8. 发明授权

US07465726B2 Substituted pyrrolo[2.3-B]pyridines 失效
标题翻译：取代的吡咯并[2,3-B]吡啶
公开(公告)号：US07465726B2
公开(公告)日：2008-12-16
申请号：US11194158
申请日：2005-08-01
申请人： Saleh Ahmed , Oscar Barba , Jason Bloxham , Graham Dawson , William Gattrell , John Kitchin , Neil Anthony Pegg , Imaad Saba , Shazia Sadiq , Colin Peter Sambrook Smith , Don Smyth , Amo G. Steinig , Robin Wilkes , Bijoy Panicker , Paula Tavares , Matthew Cox , An-Hu Li , Hanqing Dong , Lifu Ma , Kenneth (‘Ken’) Foreman , Qinghua (‘Felix’) Weng , Kathryn Stolz
发明人： Saleh Ahmed , Oscar Barba , Jason Bloxham , Graham Dawson , William Gattrell , John Kitchin , Neil Anthony Pegg , Imaad Saba , Shazia Sadiq , Colin Peter Sambrook Smith , Don Smyth , Amo G. Steinig , Robin Wilkes , Bijoy Panicker , Paula Tavares , Matthew Cox , An-Hu Li , Hanqing Dong , Lifu Ma , Kenneth (‘Ken’) Foreman , Qinghua (‘Felix’) Weng , Kathryn Stolz
IPC分类号： A61K31/437 , A61K31/496 , A61K31/5355 , A61K31/541 , A61K31/5513 , A61K31/551 , C07D471/04 , C07D223/04 , C07D243/08 , C07D241/04 , C07D413/10 , C07D413/06 , C07D413/08 , C07D413/12 , C07D413/14 , C07D417/06 , C07D417/14 , A61K31/04 , A61K31/519 , C07D487/04
CPC分类号： C07D471/02 , C07D487/02 , C07D487/04
摘要： Compounds represented by Formula (I): or stereoisomers or pharmaceutically acceptable salts thereof, are inhibitors of least two of the Abl, Aurora-A, Blk, c-Raf, cSRC, Src, PRK2, FGFR3, Flt3, Lck, Mek1, PDK-1, GSK3β, EGFR, p70S6K, BMX, SGK, CaMKII, Tie-2, IGF-1R, Ron, Ret, and KDR kinases in animals, including humans, for the treatment and/or prevention of various diseases and conditions such as cancer.
摘要翻译：由式（I）表示的化合物或其立体异构体或其药学上可接受的盐是Abl，Aurora-A，Blk，c-Raf，cSRC，Src，PRK2，FGFR3，Flt3，Lck，Mek1，PDK中的至少两种的抑制剂 -1，GSK3beta，EGFR，p70S6K，BMX，SGK，CaMKII，Tie-2，IGF-1R，Ron，Ret和KDR激酶，用于治疗和/或预防各种疾病和病症，癌症。

9. 发明申请

US20060235031A1 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors 有权
标题翻译： 6,6-双环取代杂双环蛋白激酶抑制剂
公开(公告)号：US20060235031A1
公开(公告)日：2006-10-19
申请号：US11095162
申请日：2005-03-31
申请人： Lee Arnold , Heather Coate , Andrew Crew , Hanqing Dong , Kenneth Foreman , Ayako Honda , Radoslaw Laufer , An-Hu Li , Kristen Mulvihill , Mark Mulvihill , Anthony Nigro , Bijoy Panicker , Arno Steinig , Qingua Weng , Douglas Werner , Michael Wyle , Tao Zhang , Cara Cesario , Yingchuan Sun
发明人： Lee Arnold , Heather Coate , Andrew Crew , Hanqing Dong , Kenneth Foreman , Ayako Honda , Radoslaw Laufer , An-Hu Li , Kristen Mulvihill , Mark Mulvihill , Anthony Nigro , Bijoy Panicker , Arno Steinig , Qingua Weng , Douglas Werner , Michael Wyle , Tao Zhang , Cara Cesario , Yingchuan Sun
IPC分类号： A61K31/52
CPC分类号： C07F5/025 , C07D471/04 , C07D487/04
摘要： Compounds of the formula and pharmaceutically acceptable salts thereof, wherein X1, X2, X3, X4, X5, X6, X7, R1, and Q1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.
摘要翻译：下式的化合物及其药学上可接受的盐，其中X 1，X 2，X 3，X 4， X 5，X 6，X 7，R 1和Q 1 在本文中定义，抑制IGF-1R酶，并且可用于治疗和/或预防过度增殖性疾病如癌症，炎症，牛皮癣，过敏/哮喘，免疫系统的疾病和状况，中枢的疾病和状况神经系统。

10. 发明申请

US20130261086A1 MACROCYCLIC KINASE INHIBITORS 有权
标题翻译：大环激酶抑制剂
公开(公告)号：US20130261086A1
公开(公告)日：2013-10-03
申请号：US13990045
申请日：2011-11-29
申请人： Andrew P. Crew , Hanqing Dong , Caterina Ferraro , Dan Sherman , Kam W. Siu
发明人： Andrew P. Crew , Hanqing Dong , Caterina Ferraro , Dan Sherman , Kam W. Siu
IPC分类号： C07F9/6584
CPC分类号： C07F9/6584 , A61K31/675
摘要： Compounds of Formula (I): wherein variables are defined herein, and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers for which FAK inhibition is beneficial.
摘要翻译：式（I）化合物：其中变量在本文中定义，以及其药学上可接受的盐，合成，中间体，制剂及其治疗方法，包括FAK抑制有益的癌症。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式